Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3289 to 3295 of 3295 entries
Sorted by: Best Match Show Resources per page
Comparison of Prognosis Between Hybrid Debranching Surgery and Total Open Arch Replacement With Frozen Elephant Trunk for Type A Acute Aortic Syndrome Patients.

Frontiers in cardiovascular medicine

Li J, Li L, Wang M, Li H, Sun L, Liu Y, Fan R, Zhang Z, Zou C, Zhang H, Gong M.
PMID: 34386528
Front Cardiovasc Med. 2021 Jul 27;8:689507. doi: 10.3389/fcvm.2021.689507. eCollection 2021.

No abstract available.

Cite
Li J, Li L, Wang M, et al. Comparison of Prognosis Between Hybrid Debranching Surgery and Total Open Arch Replacement With Frozen Elephant Trunk for Type A Acute Aortic Syndrome Patients. Front Cardiovasc Med. 2021;8:689507doi: 10.3389/fcvm.2021.689507.
Li, J., Li, L., Wang, M., Li, H., Sun, L., Liu, Y., Fan, R., Zhang, Z., Zou, C., Zhang, H., & Gong, M. (2021). Comparison of Prognosis Between Hybrid Debranching Surgery and Total Open Arch Replacement With Frozen Elephant Trunk for Type A Acute Aortic Syndrome Patients. Frontiers in cardiovascular medicine, 8689507. https://doi.org/10.3389/fcvm.2021.689507
Li, Jinzhang, et al. "Comparison of Prognosis Between Hybrid Debranching Surgery and Total Open Arch Replacement With Frozen Elephant Trunk for Type A Acute Aortic Syndrome Patients." Frontiers in cardiovascular medicine vol. 8 (2021): 689507. doi: https://doi.org/10.3389/fcvm.2021.689507
Li J, Li L, Wang M, Li H, Sun L, Liu Y, Fan R, Zhang Z, Zou C, Zhang H, Gong M. Comparison of Prognosis Between Hybrid Debranching Surgery and Total Open Arch Replacement With Frozen Elephant Trunk for Type A Acute Aortic Syndrome Patients. Front Cardiovasc Med. 2021 Jul 27;8:689507. doi: 10.3389/fcvm.2021.689507. eCollection 2021. PMID: 34386528; PMCID: PMC8353071.
Copy Download .nbib Format: NLM
Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients.

Frontiers in cardiovascular medicine

Myasoedova VA, Genovese S, Cavallotti L, Bonomi A, Chiesa M, Campodonico J, Rondinelli M, Cosentino N, Baldassarre D, Veglia F, Pepi M, Alamanni F, Colombo GI, Marenzi G, Poggio P.
PMID: 34386534
Front Cardiovasc Med. 2021 Jul 27;8:711899. doi: 10.3389/fcvm.2021.711899. eCollection 2021.

No abstract available.

Cite
Myasoedova VA, Genovese S, Cavallotti L, et al. Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients. Front Cardiovasc Med. 2021;8:711899doi: 10.3389/fcvm.2021.711899.
Myasoedova, V. A., Genovese, S., Cavallotti, L., Bonomi, A., Chiesa, M., Campodonico, J., Rondinelli, M., Cosentino, N., Baldassarre, D., Veglia, F., Pepi, M., Alamanni, F., Colombo, G. I., Marenzi, G., & Poggio, P. (2021). Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients. Frontiers in cardiovascular medicine, 8711899. https://doi.org/10.3389/fcvm.2021.711899
Myasoedova, Veronika A, et al. "Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients." Frontiers in cardiovascular medicine vol. 8 (2021): 711899. doi: https://doi.org/10.3389/fcvm.2021.711899
Myasoedova VA, Genovese S, Cavallotti L, Bonomi A, Chiesa M, Campodonico J, Rondinelli M, Cosentino N, Baldassarre D, Veglia F, Pepi M, Alamanni F, Colombo GI, Marenzi G, Poggio P. Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients. Front Cardiovasc Med. 2021 Jul 27;8:711899. doi: 10.3389/fcvm.2021.711899. eCollection 2021. PMID: 34386534; PMCID: PMC8354333.
Copy Download .nbib Format: NLM
Loss-of-Function Variants in the .

Frontiers in cardiovascular medicine

Clausen AG, Vad OB, Andersen JH, Olesen MS.
PMID: 33768119
Front Cardiovasc Med. 2021 Mar 09;8:650667. doi: 10.3389/fcvm.2021.650667. eCollection 2021.

Multiple genome-wide association studies (GWAS) have identified numerous loci associated with atrial fibrillation (AF). However, the genes driving these associations and how they contribute to the AF pathogenesis remains poorly understood. To identify genes likely to be driving the...

Cite
Clausen AG, Vad OB, Andersen JH, et al. Loss-of-Function Variants in the . Front Cardiovasc Med. 2021;8:650667doi: 10.3389/fcvm.2021.650667.
Clausen, A. G., Vad, O. B., Andersen, J. H., & Olesen, M. S. (2021). Loss-of-Function Variants in the . Frontiers in cardiovascular medicine, 8650667. https://doi.org/10.3389/fcvm.2021.650667
Clausen, Alexander Guldmann, et al. "Loss-of-Function Variants in the ." Frontiers in cardiovascular medicine vol. 8 (2021): 650667. doi: https://doi.org/10.3389/fcvm.2021.650667
Clausen AG, Vad OB, Andersen JH, Olesen MS. Loss-of-Function Variants in the . Front Cardiovasc Med. 2021 Mar 09;8:650667. doi: 10.3389/fcvm.2021.650667. eCollection 2021. PMID: 33768119; PMCID: PMC7985167.
Copy Download .nbib Format: NLM
Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy.

Frontiers in cardiovascular medicine

Iop L.
PMID: 33748193
Front Cardiovasc Med. 2021 Mar 04;7:591583. doi: 10.3389/fcvm.2020.591583. eCollection 2020.

Cardiovascular diseases (CVDs) still represent the primary cause of mortality worldwide. Preclinical modeling by recapitulating human pathophysiology is fundamental to advance the comprehension of these diseases and propose effective strategies for their prevention, diagnosis, and treatment.

Cite
Iop L. Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy. Front Cardiovasc Med. 2021;7:591583doi: 10.3389/fcvm.2020.591583.
Iop, L. (2020). Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy. Frontiers in cardiovascular medicine, 7591583. https://doi.org/10.3389/fcvm.2020.591583
Iop, Laura. "Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy." Frontiers in cardiovascular medicine vol. 7 (2020): 591583. doi: https://doi.org/10.3389/fcvm.2020.591583
Iop L. Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy. Front Cardiovasc Med. 2021 Mar 04;7:591583. doi: 10.3389/fcvm.2020.591583. eCollection 2020. PMID: 33748193; PMCID: PMC7969521.
Copy Download .nbib Format: NLM
Angiotensinogen and the Modulation of Blood Pressure.

Frontiers in cardiovascular medicine

Shu Z, Wan J, Read RJ, Carrell RW, Zhou A.
PMID: 33816576
Front Cardiovasc Med. 2021 Mar 18;8:645123. doi: 10.3389/fcvm.2021.645123. eCollection 2021.

The angiotensin peptides that control blood pressure are released from the non-inhibitory plasma serpin, angiotensinogen, on cleavage of its extended N-terminal tail by the specific aspartyl-protease, renin. Angiotensinogen had previously been assumed to be a passive substrate, but we...

Cite
Shu Z, Wan J, Read RJ, et al. Angiotensinogen and the Modulation of Blood Pressure. Front Cardiovasc Med. 2021;8:645123doi: 10.3389/fcvm.2021.645123.
Shu, Z., Wan, J., Read, R. J., Carrell, R. W., & Zhou, A. (2021). Angiotensinogen and the Modulation of Blood Pressure. Frontiers in cardiovascular medicine, 8645123. https://doi.org/10.3389/fcvm.2021.645123
Shu, Zimei, et al. "Angiotensinogen and the Modulation of Blood Pressure." Frontiers in cardiovascular medicine vol. 8 (2021): 645123. doi: https://doi.org/10.3389/fcvm.2021.645123
Shu Z, Wan J, Read RJ, Carrell RW, Zhou A. Angiotensinogen and the Modulation of Blood Pressure. Front Cardiovasc Med. 2021 Mar 18;8:645123. doi: 10.3389/fcvm.2021.645123. eCollection 2021. PMID: 33816576; PMCID: PMC8012498.
Copy Download .nbib Format: NLM
Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles.

Frontiers in cardiovascular medicine

Jiang W, Xiong Y, Li X, Yang Y.
PMID: 34485413
Front Cardiovasc Med. 2021 Aug 16;8:715258. doi: 10.3389/fcvm.2021.715258. eCollection 2021.

Cardiac fibrosis, a common pathophysiologic process in most heart diseases, refers to an excess of extracellular matrix (ECM) deposition by cardiac fibroblasts (CFs), which can lead to cardiac dysfunction and heart failure subsequently. Not only CFs but also several...

Cite
Jiang W, Xiong Y, Li X, et al. Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles. Front Cardiovasc Med. 2021;8:715258doi: 10.3389/fcvm.2021.715258.
Jiang, W., Xiong, Y., Li, X., & Yang, Y. (2021). Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles. Frontiers in cardiovascular medicine, 8715258. https://doi.org/10.3389/fcvm.2021.715258
Jiang, Wenyang, et al. "Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles." Frontiers in cardiovascular medicine vol. 8 (2021): 715258. doi: https://doi.org/10.3389/fcvm.2021.715258
Jiang W, Xiong Y, Li X, Yang Y. Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles. Front Cardiovasc Med. 2021 Aug 16;8:715258. doi: 10.3389/fcvm.2021.715258. eCollection 2021. PMID: 34485413; PMCID: PMC8415273.
Copy Download .nbib Format: NLM
Case Report: Transcatheter Aortic Valve Replacement in a Patient With Severe Aortic Stenosis, Left Ventricular Dysfunction, and an Anomalous Left Circumflex Artery.

Frontiers in cardiovascular medicine

Aldauig B, El-Sabbah M, Alasnag M.
PMID: 34485419
Front Cardiovasc Med. 2021 Aug 18;8:721363. doi: 10.3389/fcvm.2021.721363. eCollection 2021.

The role of cardiac computed tomography in the evaluation of patients for transcatheter aortic valve implantation is well-established. However, its role in the evaluation of anomalous vessels in the pre-procedure planning, intra-procedural fusion imaging and post-procedure assessment of vessel...

Cite
Aldauig B, El-Sabbah M, Alasnag M. Case Report: Transcatheter Aortic Valve Replacement in a Patient With Severe Aortic Stenosis, Left Ventricular Dysfunction, and an Anomalous Left Circumflex Artery. Front Cardiovasc Med. 2021;8:721363doi: 10.3389/fcvm.2021.721363.
Aldauig, B., El-Sabbah, M., & Alasnag, M. (2021). Case Report: Transcatheter Aortic Valve Replacement in a Patient With Severe Aortic Stenosis, Left Ventricular Dysfunction, and an Anomalous Left Circumflex Artery. Frontiers in cardiovascular medicine, 8721363. https://doi.org/10.3389/fcvm.2021.721363
Aldauig, Badreyah, et al. "Case Report: Transcatheter Aortic Valve Replacement in a Patient With Severe Aortic Stenosis, Left Ventricular Dysfunction, and an Anomalous Left Circumflex Artery." Frontiers in cardiovascular medicine vol. 8 (2021): 721363. doi: https://doi.org/10.3389/fcvm.2021.721363
Aldauig B, El-Sabbah M, Alasnag M. Case Report: Transcatheter Aortic Valve Replacement in a Patient With Severe Aortic Stenosis, Left Ventricular Dysfunction, and an Anomalous Left Circumflex Artery. Front Cardiovasc Med. 2021 Aug 18;8:721363. doi: 10.3389/fcvm.2021.721363. eCollection 2021. PMID: 34485419; PMCID: PMC8416351.
Copy Download .nbib Format: NLM
Showing 3289 to 3295 of 3295 entries